Rapport Therapeutics News

Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen's 4th Annual Novel Mechanisms in Neuropsychiatry Summit

GlobeNewswireAug 29 07:00 ET

TD Cowen Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)

TipRanksAug 8 14:26 ET · Ratings

Rapport Therapeutics GAAP EPS of -$1.70 Misses by $1.02

Seeking AlphaAug 8 09:33 ET

Express News | Rapport Therapeutics Ended The Quarter With $336.1M In Cash, Cash Equivalents, And Short-term Investments, Excluding Restricted Cash, Which Is Expected To Fund Operations Through The End Of 2026

BenzingaAug 8 07:58 ET

Express News | Rapport Therapeutics Q2 2024 GAAP EPS $(1.70) Misses $(0.68) Estimate

BenzingaAug 8 07:57 ET

Rapport Therapeutics | 10-Q: Quarterly report

SEC announcementAug 8 07:44 ET · Announcements

Rapport Therapeutics: Runway To Fund Operations Through End of 2026 >RAPP

Dow JonesAug 8 07:11 ET

Rapport Therapeutics 2Q Loss $18.1M >RAPP

Dow JonesAug 8 07:11 ET

Express News | Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update

ReutersAug 8 07:00 ET

Press Release: Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update

Dow JonesAug 8 07:00 ET

Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain

GlobeNewswireJul 29 07:00 ET

Rapport Therapeutics(RAPP.US) Director Buys US$1.08 Million in Common Stock

Moomoo NewsJul 3 20:44 ET

Stifel Starts Rapport at Buy, Cites Lead Drug Candidate RAP-219

Seeking AlphaJul 2 14:45 ET

TD Cowen Initiates Rapport Therapeutics(RAPP.US) With Buy Rating

Moomoo NewsJul 2 06:31 ET · Ratings

Rapport Therapeutics Analyst Ratings

BenzingaJul 2 05:53 ET

Express News | Rapport Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

ReutersJul 2 05:48 ET

Stifel Initiates Rapport Therapeutics(RAPP.US) With Buy Rating, Announces Target Price $35

Moomoo NewsJul 2 05:31 ET · Ratings

Jefferies Initiates Rapport Therapeutics(RAPP.US) With Buy Rating, Announces Target Price $35

Moomoo NewsJul 2 05:31 ET · Ratings

Buy Rating for Rapport Therapeutics: Disruptive CNS Treatments and Promising Drug Efficacy

TipRanksJul 2 04:58 ET

Express News | Rapport Therapeutics Inc : Jefferies Initiates Coverage With Buy Rating; Target Price $35

ReutersJul 2 00:35 ET